摘要:
The present invention relates to novel 4-(4-pyridyl)-benzamides of the formula (I). The compounds I possess valuable therapeutic properties and are suitable, in particular, for treating diseases that respond to modulation of Rho kinases (ROCKs). R1 and R2 are, independently of each other, hydrogen, hydroxy, cyano, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy or C1-C8-haloalkoxy; R3, R4, R5 and R6 are, independently of each other, hydrogen, hydroxy, halogen, cyano, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, amino, C1-C8-alkylamino or di-(C1-C8-alkyl)-amino; R7 is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, aryl or aryl-C1-C8-alkyl; R8 is a group of the formula —X—W, where X is a single bond, C1-C4-alkylene or C1-C4-alkylene-O—, where the alkylene group in the three last-mentioned radicals may be linear or branched and may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or may be interrupted by an oxygen atom; and W is a cyclic radical selected from phenyl and a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring which contains as ring members 1, 2 or 3 heteroatoms selected from O, S and N and optionally 1 or 2 carbonyl groups; R9 is a group of the formula —Y—Z, where Z is hydrogen, halogen, OR11, NR12R13, S(O)m—R14, phenyl which may carry 1, 2, 3 or 4 substituents R15 or a 5- or 6-membered saturated, partly unsaturated or aromatic heterocyclic ring; and Y is linear or branched C1C4-alkylene which may be partly or fully halogenated and/or may be substituted by a hydroxyl group and/or a phenyl ring; or, in case Z is phenyl or the 5- or 6-membered heterocyclic ring as defined above, Y can also be a single bond.
摘要:
The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, W, Y and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula I-A.a′ and I-A.a″ in which m, E, R1, R3a, R3b, R2, Ry, Rw and Rw6* have the meanings mentioned in the claims, n is 0, 1 or 2, the tautomers thereof and the pharmaceutically suitable salts thereof.
摘要:
The present invention relates to a composition acting as coupling agent between fillers and peroxidically crosslinking elastomers in rubber compounds, which comprises, as component comprising silicon compounds, a mixture a) of vinylalkoxysiloxanes with alkylalkoxy-siloxanes, or b) of vinylalkoxysiloxanes with phenylalkoxy-siloxanes, or c) of vinylalkoxysiloxanes with phenyl/alkyl-alkoxysiloxanes or d) of acrylic or methacrylic alkoxysiloxanes with alkylalkoxysiloxanes, or e) of acrylic or methacrylic alkoxysiloxanes with phenylalkoxysiloxanes, or f) of acrylic or methacrylic alkoxysiloxanes with phenyl/alkylalkoxysiloxanes, or g) of at least one co-oligomeric organosiloxane which, as organofunctional groups, bears at least one group from the series vinyl, acrylic and methacrylic, and at least one group from the series alkyl and phenyl, and at least one alkoxy or hydroxy group. The present invention further relates to the use of a composition of the invention as a coupling agent in filled and peroxidically crosslinking rubber compounds, to rubber compounds obtained in this way, and to items made therefrom.
摘要:
Disclosed is a functionalized polyurethane resin containing a binder component, a hardener component and, optionally, a formulation component. The binder component consists essentially of urethane dispersions with defined structural components which, in turn, consist of special reaction products. Such polyurethane resins are used for the production of fluorine-modified polyurethane coatings and generally in construction or industrial applications for the permanent oil-, water- and dirt-resistant coating of mineral and non-mineral surfaces on the basis of, for example, hydraulically setting components.
摘要:
The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, W, Y and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula I-A.a′ and I-A.a″ in which m, E, R1, R3a, R3b, R2, Ry, Rw and Rw6* have the meanings mentioned in the claims, n is 0, 1 or 2, the tautomers thereof and the pharmaceutically suitable salts thereof.
摘要:
The present Invention relates to a mixture comprising catenary, branched andfor cyclic siloxanes of the general formula (I) where x is 1, 2 or 3, the substituents R are (i) organofunctional groups selected from —CH2—SH, —CH2—S—(CO)—R′, —CH2(O—C2H4)a—OH with a =1 to 10, —CH2(O—C2H4)b—OR′ with b =1 to 40, —(CH2)—NH2, —(CH2)—NHR′, —(CH2)—NR′2, —(CH2)—NH(CH2)2—NH2, —(CH2)—N[(CH2)2—NH2]2 and —(CH2) —NH(CH2)2—NH(CH2)2—NH2, In which R′ is a linear, branched or cyclic alkyl group having 1 to 18 carbon atoms or an aryl group having 6 to 12 carbon atoms, (ii) hydroxyl, methoxy, ethoxy, 2-methoxyethoxy, isopropoxy, n-propoxy, isobutoxy andfor n-butoxy groupe, and (iii) where appropriate, alkyl, alkenyl, isoalkyl, cycloalkyl or fluorcalkyl groups having 1 to 18 carbon atoms or aryl groups having 6 to 12 carbon atoms, whit the proviso that not more than one organofunctional group (i) is attached per silicon atom, the quotient of the molar ratio of the moiety (ii) to silicon le from I to 2, and the degree of oligornerization for compounds of the general formula I is in the range from 2 to 50. The present invention also relates to a specific process for preparing said siloxane mixtures and also to their use.
摘要:
The present invention relates to a composition acting as coupling agent between fillers and peroxidically crosslinking elastomers in rubber compounds, which comprises, as component comprising silicon compounds, a mixture a) of vinylalkoxysiloxanes with alkylalkoxy-siloxanes, or b) of vinylalkoxysiloxanes with phenylalkoxy-siloxanes, or c) of vinylalkoxysiloxanes with phenyl/alkyl-alkoxysiloxanes or d) of acrylic or methacrylic alkoxysiloxanes with alkylalkoxysiloxanes, or e) of acrylic or methacrylic alkoxysiloxanes with phenylalkoxysiloxanes, or f) of acrylic or methacrylic alkoxysiloxanes with phenyl/alkylalkoxysiloxanes, or g) of at least one co-oligomeric organosiloxane which, as organofunctional groups, bears at least one group from the series vinyl, acrylic and methacrylic, and at least one group from the series alkyl and phenyl, and at least one alkoxy or hydroxy group. The present invention further relates to the use of a composition of the invention as a coupling agent in filled and peroxidically crosslinking rubber compounds, to rubber compounds obtained in this way, and to items made therefrom.
摘要:
The present invention relates to prodrugs of pharmacologically active five-membered heterocyclic amidines from which are produced in vivo compounds which are competitive inhibitors of trypsin-like serine proteases, in particular thrombin and kininogenases such as kallikrein, to the preparation thereof and to the use thereof as medicines. The invention also relates to pharmaceutical compositions which comprise the prodrugs of the active compounds as ingredients, and to the use of the compounds as thrombin inhibitors, anticoagulants and as antiinflammatory agents.
摘要:
The invention relates to 3,4-dihydro-thieno[2,3-d]pyrimidin-4-one derivatives which are substituted in position 3 by 5-membered heteroaryl which may be fused to an aryl or heteroaryl radical, where the heteroaryl and, if appropriate, the fused aryl or heteroaryl radical may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2, —NH(R6), aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl, where the substituents aryl, aryloxy, aralkyl, aralkyloxy and heteroaryl may have 1, 2 or 3 substituents selected independently of one another from C1-5-alkyl, C1-5-alkoxy, C1-5-alkylthio, halogen, CN, halo-C1-5-alkyl, halo-C1-5-alkoxy, hydroxy, —NH2, —N(R6)2 and —NH(R6). The preparation and use of these derivatives, especially for therapeutic purposes, e.g. for the treatment of depressions, are likewise described.